翰思艾泰-B

03378
22.6603.82% ( -0.900 )
延迟 已收盘: 11月20日 16:08:00

股东

全部股东

股东类型

  • 私营企业79.49%
  • 公众及其他12.05%
  • 上市公司4.72%
  • 机构投资者2.32%
  • 个人与内部人士1.43%

主要股东

主要股东 最新
股东
Cai Zhang Biotechnology (Hangzhou) Co., Ltd
40.60%5,530.00 万0.00%+0
Hanx Biopharmaceuticals (HK) Limited
13.06%1,779.36 万0.00%+0
Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership)
9.44%1,286.05 万0.00%+0
Beijing Lapam Biopharmaceutical Venture Capital Center (Limited Partnership)
9.44%1,286.05 万0.00%+0
Betta Pharmaceuticals Co., Ltd.
4.72%643.02 万0.00%+0
Wuhan Donggaorensi Equity Investment Partnership (Limited Partnership)
2.51%341.61 万0.00%+0
Wuhan Hanx Tai Management Consulting Partnership (L.P.)
2.24%304.51 万0.00%+0
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)
1.88%256.21 万0.00%+0
Yangtze Investment (HK) Limited
1.32%180.40 万0.00%+0
Qixiang LiCEO, CSO, GM & Executive Director
1.00%136.64 万0.00%+0
Tibet Lapam Small and Medium Enterprise Development Fund Equity Investment Partnership (Limited Part
0.88%119.56 万0.00%+0
Lapam Capital
0.44%59.60 万0.00%+0
Min LiuCOO, Vice GM & Executive Director
0.40%54.66 万0.00%+0
Liao Tong
0.02%2.14 万0.00%+0
Jieyu XiaoCFO, Secretary of the Board & Executive Director
<0.01%1.11 万0.00%+0
Zou Zhiyong
<0.01%1,710.000.00%+0